23andMe inks research deal with Mirador Therapeutics
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
23Andme Holding Co (ME)"23Andme Holding Co stock price live, this page displays NASDAQ ME stock exchange data. View the ME premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the 23Andme Holding Co real time stock price chart below.
What Is the 23Andme Holding Co Stock Price Today?
The 23Andme Holding Co stock price today is 3.5500.
What Is the Stock Symbol for 23Andme Holding Co?
The stock symbol for 23Andme Holding Co is ""ME.""
What Stock Exchange Does 23Andme Holding Co Trade On?
23Andme Holding Co is listed and trades on the NASDAQ stock exchange.
Is 23Andme Holding Co a Good Stock to Buy?
Determining whether 23Andme Holding Co—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ME quote. (ISIN: US90138Q3065)"
What Is the 23Andme Holding Co Stock Price Today?
The 23Andme Holding Co stock price today is 3.5500.
What Is the Stock Symbol for 23Andme Holding Co?
The stock symbol for 23Andme Holding Co is ""ME.""
What Stock Exchange Does 23Andme Holding Co Trade On?
23Andme Holding Co is listed and trades on the NASDAQ stock exchange.
Is 23Andme Holding Co a Good Stock to Buy?
Determining whether 23Andme Holding Co—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ME quote. (ISIN: US90138Q3065)"
NASDAQ
Currency in USD
3.5500
+0.4100(+13.06%)
Closed
Pre Market
3.1100-0.4400(-12.39%)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.1200
3.6300
52 wk Range
2.6550
20.4000
ME Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Unusual Pre-Market activity
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.12003.6300
52 wk Range
2.655020.4000
Key Statistics
Edit
Book Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
UnlockN/A
(N/A)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockBook Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
UnlockN/A
(N/A)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockME Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
High shareholder yield
23Andme Holding Co Company Profile
23andMe Holding Co. operates as a consumer genetics testing company in the United States, the United Kingdom, Canada, and internationally. The company operates in two segments, Consumer and Research Services, and Therapeutics. The Consumer and Research Services segment provides personal genome service (PGS) that consists of a suite of genetic reports, including information on customers’ genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications. This segments also operates Lemonaid telehealth platform to access affiliated licensed healthcare professionals for medical consultation and treatment for various common conditions; and offers research services. The Therapeutics segment focuses on the development of novel therapies; and research and development of programs in various therapeutic areas, such as oncology, immunological and inflammatory diseases, and other disease areas, as well as engages in the out-licensing of intellectual property associated with identified drug targets and expenses related to the discovery and development of therapeutic product candidates. This segment also comprises a therapeutics product portfolio, including 23ME-00610 (P006), a humanized monoclonal antibody that interfere with the ability of CD200R1 to interact with CD200 in cancer cells; GSK6097608, an immuno-oncology program for targeting CD96; and 23ME-01473 is an immuno-oncology antibody program that targets the ULBP6 proteins in the NKG2D pathway. The company has collaboration with Mirador Therapeutics to advance mirador’s precision medicines for immunology and inflammation. 23andMe Holding Co. was founded in 2006 and is headquartered in South San Francisco, California.
Compare ME to Peers and Sector
Metrics to compare | ME | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMEPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.1x | −5.0x | −0.7x | |
PEG Ratio | 0.00 | −0.10 | 0.00 | |
Price/Book | 0.9x | 2.8x | 2.6x | |
Price / LTM Sales | 0.5x | 1.7x | 3.2x | |
Upside (Analyst Target) | 136.6% | 13.6% | 44.5% | |
Fair Value Upside | Unlock | −9.6% | 6.6% | Unlock |
People Also Watch
FAQ
What Is the 23Andme Holding Co (ME) Stock Price Today?
The 23Andme Holding Co stock price today is 3.55
What Stock Exchange Does 23Andme Holding Co Trade On?
23Andme Holding Co is listed and trades on the NASDAQ stock exchange.
What Is the Stock Symbol for 23Andme Holding Co?
The stock symbol for 23Andme Holding Co is "ME."
What Is the 23Andme Holding Co Market Cap?
As of today, 23Andme Holding Co market cap is 91.72M.
What is 23Andme Holding Co Earnings Per Share?
The 23Andme Holding Co EPS is -24.95.
What Is the Next 23Andme Holding Co Earnings Date?
23Andme Holding Co will release its next earnings report on Feb 04, 2025.
From a Technical Analysis Perspective, Is ME a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.